Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Centenial Surgical
Join Channel
Consolidated Standalone

Centenial Surgical

₹103.8 -5.5 | 5%

Market Cap ₹38 Cr.

Stock P/E 34.0

P/B 1.3

Current Price ₹103.8

Book Value ₹ 82.6

Face Value 10

52W High ₹160

Dividend Yield 0%

52W Low ₹ 60.1

Edit Ratio

Centenial Surgical Research see more...

Overview Inc. Year: 1995Industry: Medical Equipment/Supplies/Accessories

Centenial Surgical Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Centenial Surgical Quarterly Results

#(Fig in Cr.) Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Jun 2023 Sep 2023 Dec 2023
Net Sales 8 12 12 12 13 13 13 14 13 12
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 8 12 12 12 13 13 13 14 13 12
Total Expenditure 7 11 11 11 12 12 12 12 12 11
Operating Profit 1 1 1 1 1 1 1 1 1 1
Interest 0 0 0 1 0 0 0 0 1 1
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 0 0 0 0 0 0 0 0
Provision for Tax 0 0 0 0 0 0 0 0 0 0
Profit After Tax 0 0 0 0 0 0 0 0 0 0
Adjustments -0 -0 0 0 0 -0 0 0 -0 0
Profit After Adjustments 0 0 0 0 0 0 0 0 0 0
Adjusted Earnings Per Share 0.2 0.7 0.6 0.2 0.8 0.8 0.8 0.8 0.6 0.8

Centenial Surgical Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 54 51 52 51 53 53 56 56 37 44 53 52
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Total Income 54 51 52 51 53 53 56 56 37 44 53 52
Total Expenditure 49 46 47 47 48 48 51 50 32 40 48 47
Operating Profit 5 5 5 5 5 5 5 6 5 5 5 4
Interest 2 1 2 2 2 2 2 2 2 2 2 2
Depreciation 1 1 1 1 1 1 1 2 2 2 1 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 3 3 3 2 3 2 3 2 2 1 1 0
Provision for Tax 1 1 1 1 1 1 1 1 1 0 1 0
Profit After Tax 2 2 2 2 2 2 2 1 1 1 1 0
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 2 2 2 2 2 2 2 1 1 1 1 0
Adjusted Earnings Per Share 4.3 4.9 5.2 4.3 4.7 4.2 5.5 3.6 2.6 1.7 2.4 3

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 20% -2% 0% -0%
Operating Profit CAGR 0% -6% 0% 0%
PAT CAGR 0% 0% -13% -7%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 63% 24% 17% 8%
ROE Average 3% 3% 4% 7%
ROCE Average 8% 8% 11% 12%

Centenial Surgical Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 17 19 21 23 24 26 28 29 30 30 31
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 2 2 1 1 1 1 1 1 1 0 0
Other Non-Current Liabilities 2 2 2 2 2 2 1 9 8 7 6
Total Current Liabilities 26 27 31 27 28 26 26 31 32 24 29
Total Liabilities 48 50 55 53 56 55 57 69 70 61 66
Fixed Assets 5 5 4 4 4 4 4 10 9 8 6
Other Non-Current Assets 0 0 0 0 0 0 0 1 0 0 1
Total Current Assets 43 45 51 49 52 51 52 58 61 53 59
Total Assets 48 50 55 53 56 55 57 69 70 61 66

Centenial Surgical Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 1 3 1 2 1 1 1 0 1 1 0
Cash Flow from Operating Activities 1 -0 0 -2 -0 2 2 2 2 5 1
Cash Flow from Investing Activities -1 -0 -0 -0 -2 -1 -1 -1 -1 -0 -0
Cash Flow from Financing Activities 2 -1 1 1 2 -1 -1 -0 -1 -5 -1
Net Cash Inflow / Outflow 2 -2 1 -1 -0 0 -1 0 -0 -0 0
Closing Cash & Cash Equivalent 3 1 2 1 1 1 0 1 1 0 0

Centenial Surgical Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 4.31 4.91 5.25 4.28 4.71 4.23 5.53 3.55 2.64 1.72 2.43
CEPS(Rs) 5.89 6.52 7.53 6.13 6.32 5.87 7.43 7.81 6.89 5.9 5.99
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 43.01 47.92 53.29 57.57 62.28 66.51 72.03 73.55 76.19 77.91 80.33
Core EBITDA Margin(%) 8.11 8.51 9.05 8.69 9.08 8.46 9.44 10.65 13.83 10.09 8.36
EBIT Margin(%) 7.59 7.52 8.28 7.48 8.17 7.44 8.44 8.02 9.88 6.76 6.13
Pre Tax Margin(%) 4.53 5.02 5.27 4.35 4.82 4.58 5.07 3.87 4.14 2.42 2.78
PAT Margin (%) 2.75 3.32 3.48 2.87 3.25 2.92 3.6 2.33 2.6 1.41 1.68
Cash Profit Margin (%) 3.76 4.41 4.99 4.11 4.36 4.06 4.84 5.12 6.8 4.85 4.15
ROA(%) 3.47 3.66 3.64 2.89 3.17 2.77 3.6 2.06 1.38 0.95 1.39
ROE(%) 10.56 10.8 10.37 7.72 7.86 6.56 7.98 4.88 3.52 2.23 3.07
ROCE(%) 15.38 13.36 14.22 11.74 14.02 14.84 16.75 12.64 8.65 7.27 8.02
Receivable days 109.39 127.86 127.54 128.23 129.93 128.11 126.33 144.58 226.09 172.23 139.05
Inventory Days 102.65 114.83 135.98 153.42 183.5 208.31 196.63 203.52 338.14 281.38 240.91
Payable days 199.43 270.35 249.01 221.97 136.29 138.3 125.05 156.01 406.55 177.73 189.11
PER(x) 4.64 9.6 9.91 15.85 15.64 19.4 8.94 9.8 16.22 35.34 25.4
Price/Book(x) 0.47 0.98 0.98 1.18 1.18 1.23 0.69 0.47 0.56 0.78 0.77
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.31 0.54 0.57 0.71 0.52 0.57 0.34 0.44 0.77 0.7 0.61
EV/Core EBITDA(x) 3.42 5.89 5.44 7.74 5.56 6.64 3.48 4.11 5.49 6.89 7.08
Net Sales Growth(%) 3.06 -5.7 1.49 -0.6 2.7 -0.18 6.27 -0.79 -33.59 20.29 18.52
EBIT Growth(%) 8.36 -6.53 12.34 -10.6 6.01 -9.05 20.47 -5.68 -18.21 -17.74 7.59
PAT Growth(%) 4.29 13.82 6.91 -18.5 10.13 -10.28 30.76 -35.74 -25.78 -34.8 41.27
EPS Growth(%) 4.29 13.82 6.91 -18.5 10.13 -10.28 30.76 -35.74 -25.78 -34.8 41.27
Debt/Equity(x) 0.72 0.59 0.58 0.58 0.05 0.05 0.04 0.44 0.46 0.31 0.32
Current Ratio(x) 1.62 1.68 1.65 1.83 1.83 1.94 2 1.87 1.92 2.2 2.04
Quick Ratio(x) 1.04 0.98 0.93 0.94 0.78 0.78 0.86 0.83 0.77 0.87 0.76
Interest Cover(x) 2.48 3.01 2.75 2.39 2.44 2.59 2.5 1.93 1.72 1.56 1.83
Total Debt/Mcap(x) 1.73 0.66 0.65 0.53 0.04 0.04 0.07 1 0.86 0.42 0.44

Centenial Surgical Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 44.78 44.78 44.78 44.78 44.78 45.48 46.89 46.89 46.89 46.89
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 55.22 55.22 55.22 55.22 55.22 54.52 53.11 53.11 53.11 53.11
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company is almost debt free.

Cons

  • Promoter holding is low: 46.89%.
  • Company has a low return on equity of 3% over the last 3 years.
  • Debtor days have increased from 177.73 to 189.11days.
  • The company has delivered a poor profit growth of -12% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Centenial Surgical News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!